HedgeChatter

  • Home /
  • Tag Archives

CPXX

Celator(R) Pharmaceuticals Announces Business Update and First Quarter 2014 Financial Results

[GlobeNewswire] – EWING, N.J. — Celator Pharmaceuticals, Inc. , a pharmaceutical company developing new and more effective therapies to treat cancer, today reported business highlights and financial results for the first … moreView todays social media effects on CPXXView the latest stocks trending across Twitter. Click to view dashboardSee who Celator is hiring next, click here to view […]

May 12, 2014 Bystocknews , Comments Off on Celator(R) Pharmaceuticals Announces Business Update and First Quarter 2014 Financial Results read more

Celator(R) Pharmaceuticals to Report First Quarter 2014 Financial Results on May 12, 2014

[GlobeNewswire] – EWING, N.J. — Celator Pharmaceuticals, Inc., , a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that it will host a conference call and live audio … moreView todays social media effects on CPXXView the latest stocks trending across Twitter. Click to view dashboardSee who Celator is hiring next, click here to view […]

May 5, 2014 Bystocknews , Comments Off on Celator(R) Pharmaceuticals to Report First Quarter 2014 Financial Results on May 12, 2014 read more

4:02 pm Celator Pharma announces start of clinical study of CPX-351 in relapsed/refractory higher risk myelodysplastic syndrome and acute myeloid leukemia patients

moreView todays social media effects on CPXXView the latest stocks trending across Twitter. Click to view dashboardSee who Celator is hiring next, click here to view […]

March 27, 2014 Bystocknews , Comments Off on 4:02 pm Celator Pharma announces start of clinical study of CPX-351 in relapsed/refractory higher risk myelodysplastic syndrome and acute myeloid leukemia patients read more